A randomized, double-blinded, controlled study to evaluate the efficacy of test products in providing skin moisturization and barrier protection for up to 24 hours in healthy subjects.

Abbott India Limited0 个研究点目标入组 30 人开始时间: 待定最近更新: 2024年1月22日

试验速览

暂无简介。

•1. Healthy female subjects, as determined from a recent medical history.
•2. Subjects in the age group of 18-45 years (both ages inclusive).
•3. Subjects who present normal to dry skin on the forearm (corneometer value of 35 as maximum)
•4. Healthy skin in the test sites.
•5. Subjects willing to give voluntary written informed consent and agree to come for regular follow-up.
•6. Subjects willing to abide by and comply with the study protocol.
•7. Subjects who are willing not to participate in any other clinical study during participation in the current study.

•1. Excessive hair on the test site
•2. A known history or present condition of an allergic response to any cosmetic products.
•3. Change personal nutrition habits as well as sports habits
•4. Start or change their oral hormonal treatment or their oral contraception
•5. Subject having active skin diseases (e.g., active atopic dermatitis, pigmented contact dermatitis or other cutaneous manifestations), which will interfere with the assessment.
•6. Subjects on oral medications (e.g. steroids, anti-oxidant) which will compromise the study.
•7. Subjects had cancer in the last 10 years
•8. Subjects with wounds, sunburn, scars, tattoos or piercings at the skin test site(s)
•9. Subjects with application of ointments, creams etc. for antibacterial, anti-allergic or immunosuppressive treatment of the skin at the test site(s)
•10. Systemic treatment which may modify the cutaneous state on the day of inclusion or in the previous 30 days, including retinoid therapy.
•11. History of intense sun exposure and/ photo toxicity/allergy.
•12. Female subjects who are pregnant, lactating or nursing.
•13. Chronic illness which may influence the cutaneous state.
•14. Subject participating in any other cosmetic or therapeutic trial.
•15. Any underlying uncontrolled medical illness including diabetes mellitus, hypertension, liver disease or history of alcoholism, HIV, hepatitis, or any other serious medical illness.

发起方